Vilobelimab Completed Phase 2 Trials for C.Surgical Procedure; Cardiac / Systemic Inflammatory Response Syndrome (SIRS) Treatment

Indications	Status	Purpose	Phase
DBCOND0039800 (C.Surgical Procedure; Cardiac) DBCOND0053489 (Systemic Inflammatory Response Syndrome (SIRS))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT02866825	Studying Complement Inhibition in Complex Cardiac Surgery	Vilobelimab (DB16416)